| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/12/2009 | US20090069442 Therapeutic Agent for Sensory Abnormality |
| 03/12/2009 | US20090069435 Bridged polycyclic compound based compositions for topical applications for pets |
| 03/12/2009 | US20090069413 Deuterium-enriched olopatadine |
| 03/12/2009 | US20090069371 Isoquinoline compounds |
| 03/12/2009 | US20090069345 Pharmaceutically Stable Compound Consisting of Timolol, Dorzolamide and Brimonidine |
| 03/12/2009 | US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity |
| 03/12/2009 | US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor |
| 03/12/2009 | US20090069301 Acridine and Quinoline Derivatives as Sirtuin Modulators |
| 03/12/2009 | US20090069238 Activatable clostridial toxins |
| 03/12/2009 | US20090069236 PROCESS FOR THE PREPARATION OF HYPOALLERGENIC MAJOR BIRCH POLLEN ALLERGEN rBet v 1 |
| 03/12/2009 | US20090069231 Compositions and methods for treating diabetic eye disease |
| 03/12/2009 | US20090069225 Somatostatin analogues |
| 03/12/2009 | US20090068198 Antibody and Uses Thereof |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
| 03/12/2009 | CA2698695A1 Method of treating glaucoma using rasagiline |
| 03/12/2009 | CA2698651A1 Eye drop containing dibenz [b,e] oxepin derivative |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033951A2 2-Piperazine-pyridines useful for treating pain |
| 03/11/2009 | EP2033649A1 Pharmaceutical composition for treatment of ocular hypertension |
| 03/11/2009 | EP2033648A2 Sustained release drug delivery system containing codrugs |
| 03/11/2009 | EP2033644A1 Spiroindene and spiroindane compounds |
| 03/11/2009 | EP2032573A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 03/11/2009 | EP2032142A2 Novel compounds |
| 03/11/2009 | EP2032130A2 Ophthalmic compositions for treating ocular hypertension |
| 03/11/2009 | EP2031965A2 Novel compounds |
| 03/11/2009 | EP1534202B1 Ophthalmic drug delivery system |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1379550B1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1268799B1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 03/11/2009 | EP1185255B1 RETINOPROTECTIVE OPHTHALMOLOGIC MEDICINES comprising ramipril or ramiprilat |
| 03/11/2009 | CN101384704A Resorbable cornea button |
| 03/11/2009 | CN101380395A Traditional Chinese medicine composition for preventing and treating ophthalmic diseases and preparation method thereof |
| 03/11/2009 | CN101380319A Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 03/11/2009 | CN100467476C Derivatives of branched-chain lipophilic molecules and uses thereof |
| 03/11/2009 | CN100467469C A2b adenosine receptor antagonists |
| 03/11/2009 | CN100467450C Anthranilic acid amides and pharmaceutical use thereof |
| 03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 03/11/2009 | CN100467066C Eye drip liquid which improves permeability by containing agar |
| 03/10/2009 | US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents |
| 03/10/2009 | US7501425 e.g. 1-Methyl-7-[4-(pyrazol-1-yl)phenylamino]pyrimido[4,5-d]pyrimidin-2(1H)-one; anticarcinogenic agents; restenosis, angiogenesis and atherosclerosis |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/10/2009 | US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens |
| 03/10/2009 | US7501115 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 03/05/2009 | WO2009029762A2 Farnesylamine inhibitors of the visual cycle |
| 03/05/2009 | WO2009028674A1 Latanoprost-containing aqueous pharmaceutical composition |
| 03/05/2009 | WO2009028631A1 Agent for promoting corneal endothelial cell adhesion |
| 03/05/2009 | WO2009027753A1 Composition and method inhibiting inflammation |
| 03/05/2009 | WO2009026717A1 Inhibitors of protein tyrosine kinase activity |
| 03/05/2009 | WO2009010455A3 Pyrazole derivatives as modulators of metabotropic glutamate receptors |
| 03/05/2009 | WO2009007746A3 Treatment of sensorineural hearing loss |
| 03/05/2009 | WO2008108322A3 Composition and method for protecting mitochondria |
| 03/05/2009 | US20090062561 Deuterium-enriched latanoprost |
| 03/05/2009 | US20090062400 Method of treating glaucoma using rasagiline |
| 03/05/2009 | US20090062361 Therapeutic hydantoins |
| 03/05/2009 | US20090062353 Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| 03/05/2009 | US20090062308 Methods of using sodium channel blockers |
| 03/05/2009 | US20090062296 Nitrooxyderivatives of prostaglandin amides, e.g., N-(3-(nitrooxy)propyl) 1R-[1 alpha (Z),2 beta (R*),3 alpha ,5 alpha ]]-7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-5-heptenamide; reduced side effects,wider pharmacological activity, enhanced tolerability, long-acting hypotensive activity |
| 03/05/2009 | US20090062249 An intraocular, biodegradable drug delivery system comprising anecortave acetate and a biodegradable glycolic acid-lactic acid copolymer effective in releasing the immunosuppressant into the eye over a period of > 3 weeks; sustained release from a single pellet or a single extruded filament |
| 03/05/2009 | US20090062188 Disease-Associated Protein |
| 03/05/2009 | US20090061025 Compositions and methods for treating demodex infestations |
| 03/05/2009 | US20090061023 Nutritional supplement |
| 03/05/2009 | US20090060980 Glycan binding proteins as therapeutic targets for retinal disorders and treatment methods based thereon |
| 03/05/2009 | US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 03/05/2009 | US20090060909 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 03/05/2009 | DE102007040615A1 Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen Osmolytes for treating allergic or viral respiratory diseases |
| 03/05/2009 | CA2697895A1 Agent for promoting corneal endothelial cell adhesion |
| 03/05/2009 | CA2697795A1 Inhibitors of protein tyrosine kinase activity |
| 03/04/2009 | EP2029518A2 Cyclopentane-derivatives and their use as ocular hypotensive agents |
| 03/04/2009 | EP2029232A1 Antibacterial extracellular polysaccharide solvating system |
| 03/04/2009 | EP1740198A4 Anti-aging effects of substance p |
| 03/04/2009 | EP1521572B1 Bioerodible film for ophthalmic drug delivery |
| 03/04/2009 | EP1506951B1 Method for the preparation of total salvianolic acid |
| 03/04/2009 | EP1490071B1 Therapeutic uses of sapogenins |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
| 03/04/2009 | EP1452527B1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 03/04/2009 | EP1427720B1 3-substituted-4-pyrimidone derivatives |
| 03/04/2009 | CN101375848A Fluconazole eye gel |
| 03/04/2009 | CN100464751C Matrine eye drip liquid and a production method thereof |
| 03/03/2009 | US7498435 One amine is substituted with a fused heterocyclic ring and the other with a fused heterocyclic ring or phenyl ring, e.g., N2,N4-Bis(3,4-ethylenedioxyphenyl)-5-cyano-2,4-pyrimidinediamine; inhibit IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators such as histamine |
| 03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 03/03/2009 | US7498416 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/03/2009 | US7498360 Adminisering prostaglandin into ear |
| 03/03/2009 | US7498352 TGF-β superfamily production/secretion promoter |
| 03/03/2009 | US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
| 03/03/2009 | US7498031 Treating sensorineural hearing loss or a vestibular disorder by administering an a PM-1antibody or an MR16-1 antibody; Meniere's disease, drug-induced inner ear disorders, viral inner ear disorders, purulent inner ear disorders, temporal bone fracture or acoustic nerve tumor |
| 03/03/2009 | CA2280089C Compositions and methods for reducing ocular hypertension |
| 02/26/2009 | WO2009026009A1 Compositions and methods for modulating endophthalmitis using fluoroquinolones |
| 02/26/2009 | WO2009024677A2 Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection |
| 02/26/2009 | WO2009024346A2 The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases |
| 02/26/2009 | WO2009023943A1 Pharmaceutical association, compositions for topical use, forms of dosage and method of treatment of acute or chronic otitis in pet animals |
| 02/26/2009 | WO2008143642A3 Methods of treating and preventing ocular neovascularization with omega-3 polyunsaturated fatty acids |
| 02/26/2009 | US20090054532 Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation |
| 02/26/2009 | US20090054531 Eye drop preparation comprising xanthan gum and terpenoid |